Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.53%
0%
-5.53%
6 Months
-4.45%
0%
-4.45%
1 Year
8.66%
0%
8.66%
2 Years
-2.04%
0%
-2.04%
3 Years
15.49%
0%
15.49%
4 Years
-15.14%
0%
-15.14%
5 Years
12.73%
0%
12.73%
Nanjing Well Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
10.61%
EBIT Growth (5y)
6.30%
EBIT to Interest (avg)
13.70
Debt to EBITDA (avg)
0.97
Net Debt to Equity (avg)
0.15
Sales to Capital Employed (avg)
0.57
Tax Ratio
15.38%
Dividend Payout Ratio
37.00%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.61%
ROE (avg)
7.02%
Valuation key factors
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
2.07
EV to EBIT
23.23
EV to EBITDA
12.94
EV to Capital Employed
1.92
EV to Sales
3.01
PEG Ratio
2.11
Dividend Yield
1.52%
ROCE (Latest)
8.25%
ROE (Latest)
8.07%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
321.80
347.50
-7.40%
Operating Profit (PBDIT) excl Other Income
76.20
77.90
-2.18%
Interest
3.00
2.90
3.45%
Exceptional Items
0.00
0.00
Consolidate Net Profit
35.50
35.80
-0.84%
Operating Profit Margin (Excl OI)
132.90%
128.10%
0.48%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is -7.40% vs 18.04% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -0.84% vs 4.68% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
1,288.10
1,148.50
12.15%
Operating Profit (PBDIT) excl Other Income
284.70
204.90
38.95%
Interest
14.30
15.50
-7.74%
Exceptional Items
12.10
1.40
764.29%
Consolidate Net Profit
145.20
109.10
33.09%
Operating Profit Margin (Excl OI)
130.80%
115.00%
1.58%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 12.15% vs 4.09% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is 33.09% vs 15.57% in Dec 2023
About Nanjing Well Pharmaceutical Co., Ltd. 
Nanjing Well Pharmaceutical Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






